Franz Inc./Franz Biotech Inc. is the global leader in ceramic 3D printing technologies and provides additive solutions to help customers to manufacture various electronic components with light, thin and short in size. Their application fields cover medical devices, semiconductors, information and communication technology products, and other emerging products. With our 3D-print services, we can assist many industries in the development of customized electronics, such as nanosatellites, 5G/6G mobile phone antennas, machined components, and electronics products, which help to optimize traditional manufacturing procedures. Here, as compared with other ceramic 3D printing technologies, the most unique feature of our creative 3D printing fabrication is that it can print extremely fine models without any support structures. For details, please refer to https://3d.franzcollection.com.tw/
Recently, we have also achieved success in the development of medical device. In 2020, the "3D printed all-ceramic crown" was officially proved by the TFDA. It is the only one that has passed the TFDA certification. Besides, the USA FDA certification is expected to pass by Q1, 2022. In 2021, Franz Inc./Franz Biotech Inc. cooperates with the NYCU interdisciplinary team of Memory Engrams Research (funded by Taiwan Brain Technology Development and International Raising Program, Ministry of Science and Technology) to develop a next generation of ceramic 3D-printed neural chip, which can be used for preclinical studies in diagnosis and treatment of neurodegenerative diseases. We are expected to promote ceramic 3D printing technology to the market of clinical medical devices in the future.